Healthcare Costs

A novel therapy that disarms rather than kills a deadly superbug offers a glimpse of a post-antibiotic future for patients with a debilitating lung disease.

As nurses and PAs become central to care, new systems are needed. Motive's expanded platform creates a single standard for a new era of team medicine.

Beyond beta-blockers, a new class of targeted therapies is revolutionizing hypertrophic cardiomyopathy care, sparking a fierce corporate race for market dominance.

As healthcare costs soar, Maven Clinic convenes industry titans to tackle the future of family benefits, betting that collaborative innovation is the only way forward.

Intermountain Health becomes the first to deploy an FDA-approved AI, aiming to eliminate the dreaded second surgery for thousands of breast cancer patients.

Landing on the Inc. 5000 is just the headline. The real story is how iScribeHealth's ambient AI is tackling healthcare's $43B paperwork crisis.

Rigel's VEPPANU is the first FDA-approved PROTAC, a new class of drug that destroys disease proteins. This is the story behind the science and the numbers.

As physician shortages and student debt mount, a key medical institution doubles its scholarship program. Is this philanthropy, or a strategic pivot?

A New York non-profit's monthly alert reveals the street-level tactics of a massive illicit industry. But the real story is the multi-front war being waged by regulators and citizens against a fraud enterprise that costs taxpayers billions.

OneDigital's new AI platform promises to shift benefits from a cost-cutting exercise to a strategic investment. But does it work? A deep dive.

A new report reveals undiagnosed testosterone deficiency could cost the U.S. up to $525 billion, but the real story is about the millions of men being missed.

A bureaucratic blunder in Florida's Medicaid funding has ignited a legal battle, leaving millions of families fearing the loss of their children's doctors.

Healthcare Management Administrators appoints Diane Zalewski as CEO. Her Evernorth success signals a focus on innovation amid rising costs for self-funded employers.

As autism care costs spiral toward $1 billion, a new partnership aims to dismantle a flawed model, moving beyond ABA to integrated care. Is this the fix?

With Mike Morgan as new CCO, Transcarent bets its 'agentic AI' can finally solve the puzzle of employer health benefits and win a consolidating market.

A strategic acquisition promises to merge AI-powered provider guidance with proven cost-saving models. Can it finally deliver on the elusive goal of better, cheaper healthcare?

With a strategic investment from UMass Memorial Health, Wellinks is scaling its predictive tech to prevent crises before they start. A new model for chronic care.

Gen Z spends big on self-care but avoids the doctor's office, turning to AI first. This trend creates a wellness paradox, straining the health system.

A new study claims nearly half of Medicaid expansion enrollees are ineligible. Is this a fiscal crisis or a distraction from a vital safety net?

Demand for medical aid for COVID vaccine injuries has surged 33%, but government help is scarce. A small charity is now a last hope for thousands.